Medicine

Havas Launches GLP-1 Focused Content Platform

January 12, 2025 - By 

‘Shape Shifting’ is a creator-led series that focuses on the scientific and cultural impact of GLP-1s.

Related Posts

FDA Approves Samsung Bioepis Biosimilars Ospomyv and Xbryk

February 19, 2025

Navigating Distrust: Pharma in the Age of Social Media

February 19, 2025

Pharmaceutical Executive: February 2025 Issue (PDF)

February 18, 2025

Leave a Reply

Your email address will not be published. Required fields are marked *